Admedus taps investors for $28m

Biotech company Admedus has initiated a capital raising comprising a placement and rights issue, with the hope of generating up to $28 million to fund ongoing development of various health care programs.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Client advisers

4th-Bell Potter Securities31
5th↑Macquarie Group29
6th-Morgans Financial25
7th↓CPS Capital Group25
8th↑Morgan Stanley Wealth Management20
21 stockbrokers ranked by number of client advisers in WA

BNiQ Disclaimer